COMMUNIQUÉS West-GlobeNewswire

Align Technology Hosts 2018 Investor Day
23/05/2018
Highlights Innovative Digital Platform Reinforces Strong Company Growth Reaffirms Guidance Announces Stock Repurchase Program NEW YORK, May 23, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) will host [...]
AxoGen, Inc. to Present at the Jefferies Global Healthcare Conference
23/05/2018
ALACHUA, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, [...]
ProQR Appoints Yi-Tao Yu, Ph.D., to Its Scientific Advisory Board
23/05/2018
LEIDEN, the Netherlands, May 23, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR ), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]
Clementia Reports Positive Phase 2 Part B Data Showing Treatment with Palovarotene Significantly Reduces New Bone Growth in Patients with FOP
23/05/2018
Statistically Significant 91% Reduction of New HO at Flare-up Sites at 12 Weeks; 65% Reduction of New HO at 12-Month WBCT Scan Evaluable Patients with No New Bone at 12 Weeks Had No New Bone at 12 Months Company to Host [...]
Clementia annonce l’obtention de données positives de la partie B de la phase 2 démontrant que le traitement par palovarotene peut considérablement réduire le développement d’une nouvelle croissance osseuse chez des patients souffrant de FOP
23/05/2018
Réduction statistiquement significative de 91 % de nouvelle OH aux sites de poussées à la semaine 12; réduction de 65% de nouvelle OH lors de la TDM du corps entier au mois 12 Les patients évaluables n’ayant pas [...]
Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors
23/05/2018
Press release Malmö, May 23, 2018 Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors Acarix, developer of the CADScor®System for Coronary Artery Disease (CAD) risk [...]
PotNetwork Holdings' Diamond CBD, Inc. Puts Smack Down on Bullying Through Alliance with Former MMA Pro,Carlos Flores, and the Bully Rehab Awareness Gym
23/05/2018
Company Moves to Break Into MMA, the Fastest-Growing Sport on the Planet FT. LAUDERDALE, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) is pleased to announce that [...]
Capital Senior Living Corporation to Present at the Jefferies 2018 Healthcare Conference on Tuesday, June 5, 2018
23/05/2018
DALLAS, May 23, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that management will make a [...]
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Enter into Ex-U.S. Licensing Agreement to Commercialize KORSUVA™ Injection in Dialysis Patients with Pruritus
23/05/2018
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million Cara eligible for up to $470 million in regulatory and commercial milestones VFMCRP to commercialize KORSUVA injection [...]
Solon Eiendom ASA : Annual general Meeting held 23 May 2018
23/05/2018
Oslo, 23 May 2018: Solon Eiendom ASA (OSE: SOLON) held annual general meeting at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 23 May 2018. The general meeting resolved the board's proposal of a [...]
Lundbeck increases its share capital by 41,946 shares (0.0211 % of outstanding shares) as a result of exercise of employee warrants
23/05/2018
Valby, Denmark, 23 May 2018 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 209,730 as a consequence of the exercise of employee warrants. The increase is effected [...]
Acarix AB recruits Per Persson as Chief Commercial Officer
23/05/2018
Press release Malmö, May 23, 2018 Acarix AB recruits Per Persson as Chief Commercial Officer Acarix AB (publ) ("Acarix"), today announced the recruitment of Per Persson as new Chief Commercial Officer to accelerate the [...]
New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication
23/05/2018
Late-Breaking SPYRAL HTN-ON MED Study at EuroPCR Indicates RDN Lowers Blood Pressure in Hypertensive Patients in Presence of BP Medication DUBLIN and PARIS - May 23, 2018 - Medtronic plc (NYSE: MDT ) today announced [...]
Navamedic ASA: Invitation to presentation of first quarter 2018
23/05/2018
Navamedic ASA invites you to a presentation of the first quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Wednesday 30 May. The presentation will start at 08.00 The [...]
Allscripts Sunrise™ powers The Dudley Group NHS Foundation Trust to transform delivery of care
23/05/2018
One of the country’s largest teaching hospitals leads the way in connecting the health economy in U.K. and provides tools to increase efficiency in an era of ever greater demand DUDLEY, United Kingdom, May 23, 2018 ( [...]
FIT Biotech Oy: FIT Biotech files two international patent applications
23/05/2018
FIT Biotech Oy Company release 23.5.2018 at 9.30 EET FIT Biotech files two international patent applications FIT Biotech Oy ("company", FITBIO:FN Finland) has filed two international patent applications. These [...]
Acarix Interim Report, January - March 2018 : CADScor®System launched in key markets
23/05/2018
Interim Report, January - March 2018 Malmö, May 23, 2018 CADScor®System launched in key markets "Acarix introduced the CADScor®System on the German, Swedish and Danish markets 11 months ago, in June 2017. The [...]
ThromboGenics to present a preclinical overview of its two most advanced diabetic eye disease clinical candidates, THR-317 and THR-149, at EASDec 2018
23/05/2018
Press release Leuven, Belgium, 23 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that its CSO Jean Feyen, PhD, and Senior [...]
Shire plc : Rule 2.9 Announcement
23/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 May 2018 Shire [...]

Pages